US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 47.100
  • -0.410-0.86%
Close May 17 16:00 ET
  • 47.100
  • 0.0000.00%
Post 16:02 ET
2.44BMarket Cap-39250P/E (TTM)

Janux Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.66%-14.84M
-17.83%-50.58M
16.89%-9.9M
12.71%-11.71M
-147.88%-15.05M
-20.73%-13.91M
-152.84%-42.92M
-13.66%-11.91M
-129.14%-13.41M
2.11%-6.07M
Net income from continuing operations
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
-55.08%-16.7M
-172.12%-16.89M
Depreciation and amortization
17.44%532K
132.46%1.96M
31.76%531K
100.80%500K
336.11%471K
459.26%453K
644.25%841K
529.69%403K
822.22%249K
730.77%108K
Change In working capital
-535.29%-4.45M
-253.27%-6.55M
-231.10%-1.1M
-287.55%-3.08M
-126.36%-1.68M
67.09%-700K
-51.64%4.28M
5,673.33%836K
-133.15%-795K
606.53%6.36M
-Change in receivables
30.80%-519K
----
----
----
----
---750K
----
----
----
----
-Change in prepaid assets
-171.01%-1.17M
106.23%210K
433.33%270K
140.74%530K
-281.43%-2.24M
217.79%1.65M
-86.65%-3.37M
-400.00%-81K
-2,925.58%-1.3M
66.95%-587K
-Change in payables and accrued expense
-204.20%-2.03M
-110.38%-401K
-38.68%753K
-178.07%-1.76M
3,537.84%1.27M
-259.57%-667K
-25.26%3.86M
-14.66%1.23M
-24.72%2.25M
-105.89%-37K
-Change in other current assets
93.21%-15K
11.89%-1.12M
37.70%-195K
110.42%119K
-732.31%-822K
-501.82%-221K
-223.98%-1.27M
-24.21%-313K
-715.71%-1.14M
--130K
-Change in other working capital
-0.28%-713K
-203.78%-5.24M
-286.35%-1.92M
-1,777.14%-1.97M
-109.31%-638K
40.75%-711K
337.45%5.05M
59.48%-498K
86.66%-105K
6,448.15%6.86M
Cash from discontinued investing activities
Operating cash flow
-6.66%-14.84M
-17.83%-50.58M
16.89%-9.9M
12.71%-11.71M
-147.88%-15.05M
-20.73%-13.91M
-152.84%-42.92M
-13.66%-11.91M
-129.14%-13.41M
2.11%-6.07M
Investing cash flow
Cash flow from continuing investing activities
-1,201.33%-113.74M
-170.70%-41.19M
793.45%11.12M
-410.94%-61.45M
97.74%17.87M
-128.13%-8.74M
117.09%58.27M
-121.89%-1.6M
109.62%19.76M
106.34%9.04M
Net PPE purchase and sale
30.88%-197K
71.30%-1.85M
74.95%-515K
81.35%-470K
35.41%-580K
70.65%-285K
-334.89%-6.45M
-75.28%-2.06M
-3,172.73%-2.52M
-1,036.71%-898K
Net investment purchase and sale
-1,242.86%-113.54M
-160.80%-39.34M
2,474.78%11.64M
-373.67%-60.98M
85.71%18.45M
-126.39%-8.46M
119.06%64.71M
-94.68%452K
110.85%22.28M
106.97%9.94M
Cash from discontinued investing activities
Investing cash flow
-1,201.33%-113.74M
-170.70%-41.19M
793.45%11.12M
-410.94%-61.45M
97.74%17.87M
-128.13%-8.74M
117.09%58.27M
-121.89%-1.6M
109.62%19.76M
106.34%9.04M
Financing cash flow
Cash flow from continuing financing activities
20,290.57%322.17M
11,809.60%59.55M
335.08%831K
56.61M
71.43%528K
157,900.00%1.58M
-99.87%500K
16.46%191K
0
-99.91%308K
Net common stock issuance
--320.51M
--56.53M
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
4.87%1.66M
503.60%3.02M
335.08%831K
--79K
71.43%528K
157,900.00%1.58M
-72.38%500K
16.46%191K
--0
--308K
Cash from discontinued financing activities
Financing cash flow
20,290.57%322.17M
11,809.60%59.55M
335.08%831K
--56.61M
71.43%528K
157,900.00%1.58M
-99.87%500K
16.46%191K
--0
-99.91%308K
Net cash flow
Beginning cash position
-61.68%20.02M
43.53%52.24M
-72.60%17.97M
-41.71%34.52M
-44.28%31.17M
43.53%52.24M
365.86%36.4M
66.46%65.57M
-76.47%59.22M
-20.95%55.95M
Current changes in cash
1,018.79%193.6M
-303.36%-32.22M
115.41%2.05M
-360.69%-16.55M
2.26%3.35M
-207.80%-21.07M
-44.57%15.84M
-345.54%-13.33M
102.99%6.35M
-98.19%3.27M
End cash Position
585.31%213.62M
-61.68%20.02M
-61.68%20.02M
-72.60%17.97M
-41.71%34.52M
-44.28%31.17M
43.53%52.24M
43.53%52.24M
66.46%65.57M
-76.47%59.22M
Free cash flow
-5.90%-15.03M
-6.19%-52.43M
25.43%-10.42M
23.57%-12.18M
-124.27%-15.63M
-13.63%-14.2M
-167.46%-49.37M
-19.86%-13.97M
-168.66%-15.93M
-10.95%-6.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.66%-14.84M-17.83%-50.58M16.89%-9.9M12.71%-11.71M-147.88%-15.05M-20.73%-13.91M-152.84%-42.92M-13.66%-11.91M-129.14%-13.41M2.11%-6.07M
Net income from continuing operations 15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M-55.08%-16.7M-172.12%-16.89M
Depreciation and amortization 17.44%532K132.46%1.96M31.76%531K100.80%500K336.11%471K459.26%453K644.25%841K529.69%403K822.22%249K730.77%108K
Change In working capital -535.29%-4.45M-253.27%-6.55M-231.10%-1.1M-287.55%-3.08M-126.36%-1.68M67.09%-700K-51.64%4.28M5,673.33%836K-133.15%-795K606.53%6.36M
-Change in receivables 30.80%-519K-------------------750K----------------
-Change in prepaid assets -171.01%-1.17M106.23%210K433.33%270K140.74%530K-281.43%-2.24M217.79%1.65M-86.65%-3.37M-400.00%-81K-2,925.58%-1.3M66.95%-587K
-Change in payables and accrued expense -204.20%-2.03M-110.38%-401K-38.68%753K-178.07%-1.76M3,537.84%1.27M-259.57%-667K-25.26%3.86M-14.66%1.23M-24.72%2.25M-105.89%-37K
-Change in other current assets 93.21%-15K11.89%-1.12M37.70%-195K110.42%119K-732.31%-822K-501.82%-221K-223.98%-1.27M-24.21%-313K-715.71%-1.14M--130K
-Change in other working capital -0.28%-713K-203.78%-5.24M-286.35%-1.92M-1,777.14%-1.97M-109.31%-638K40.75%-711K337.45%5.05M59.48%-498K86.66%-105K6,448.15%6.86M
Cash from discontinued investing activities
Operating cash flow -6.66%-14.84M-17.83%-50.58M16.89%-9.9M12.71%-11.71M-147.88%-15.05M-20.73%-13.91M-152.84%-42.92M-13.66%-11.91M-129.14%-13.41M2.11%-6.07M
Investing cash flow
Cash flow from continuing investing activities -1,201.33%-113.74M-170.70%-41.19M793.45%11.12M-410.94%-61.45M97.74%17.87M-128.13%-8.74M117.09%58.27M-121.89%-1.6M109.62%19.76M106.34%9.04M
Net PPE purchase and sale 30.88%-197K71.30%-1.85M74.95%-515K81.35%-470K35.41%-580K70.65%-285K-334.89%-6.45M-75.28%-2.06M-3,172.73%-2.52M-1,036.71%-898K
Net investment purchase and sale -1,242.86%-113.54M-160.80%-39.34M2,474.78%11.64M-373.67%-60.98M85.71%18.45M-126.39%-8.46M119.06%64.71M-94.68%452K110.85%22.28M106.97%9.94M
Cash from discontinued investing activities
Investing cash flow -1,201.33%-113.74M-170.70%-41.19M793.45%11.12M-410.94%-61.45M97.74%17.87M-128.13%-8.74M117.09%58.27M-121.89%-1.6M109.62%19.76M106.34%9.04M
Financing cash flow
Cash flow from continuing financing activities 20,290.57%322.17M11,809.60%59.55M335.08%831K56.61M71.43%528K157,900.00%1.58M-99.87%500K16.46%191K0-99.91%308K
Net common stock issuance --320.51M--56.53M--0----------0--0--0--------
Proceeds from stock option exercised by employees 4.87%1.66M503.60%3.02M335.08%831K--79K71.43%528K157,900.00%1.58M-72.38%500K16.46%191K--0--308K
Cash from discontinued financing activities
Financing cash flow 20,290.57%322.17M11,809.60%59.55M335.08%831K--56.61M71.43%528K157,900.00%1.58M-99.87%500K16.46%191K--0-99.91%308K
Net cash flow
Beginning cash position -61.68%20.02M43.53%52.24M-72.60%17.97M-41.71%34.52M-44.28%31.17M43.53%52.24M365.86%36.4M66.46%65.57M-76.47%59.22M-20.95%55.95M
Current changes in cash 1,018.79%193.6M-303.36%-32.22M115.41%2.05M-360.69%-16.55M2.26%3.35M-207.80%-21.07M-44.57%15.84M-345.54%-13.33M102.99%6.35M-98.19%3.27M
End cash Position 585.31%213.62M-61.68%20.02M-61.68%20.02M-72.60%17.97M-41.71%34.52M-44.28%31.17M43.53%52.24M43.53%52.24M66.46%65.57M-76.47%59.22M
Free cash flow -5.90%-15.03M-6.19%-52.43M25.43%-10.42M23.57%-12.18M-124.27%-15.63M-13.63%-14.2M-167.46%-49.37M-19.86%-13.97M-168.66%-15.93M-10.95%-6.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg